Cara Therapeutics Inc. sell StockNews.com
Start price
06.04.25
/
50%
€0.37
Target price
06.04.26
-
Performance (%)
-
End price
07.04.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cara Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -0,22 % | 1,75 % | 2,66 % |
| iShares Nasdaq 100 | -2,35 % | 0,22 % | 32,49 % |
| iShares Nikkei 225® | -3,10 % | 2,93 % | 56,98 % |
| iShares S&P 500 | -0,50 % | 1,99 % | 24,47 % |
Comments by StockNews_com for this prediction
In the thread Cara Therapeutics Inc. diskutieren
Cara Therapeutics, Inc. (NASDAQ: CARA) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CARA provided by MarketBeat
In the thread Trading Cara Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Cara Therapeutics Inc.
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
17.02.24
17.02.24
-
17.02.25
17.02.25
-25.51%
18.02.25
18.02.25
